Estamos realizando la búsqueda. Por favor, espere...
1583
37
170
29013
4402
2599
347
386
Abstract: Purpose: The aim of our study was to elucidate the impact of bevacizumab added to neoadjuvant chemotherapy (NACT) on the tumor immune microenvironment and correlate the changes with the clinical outcome of the patients. Experimental design: IHC and multiplex immunofluorescence for lymphoid and myeloid lineage markers were performed in matched tumor samples from 23 patients with ovarian cancer enrolled in GEICO 1205/NOVA clinical study before NACT and at the time of interval cytoreductive surgery. Results: Our results showed that the addition of bevacizumab to NACT plays a role mainly on lymphoid populations at the stromal compartment, detecting a significant decrease of CD4+ T cells, an increase of CD8+ T cells, and an upregulation in effector/regulatory cell ratio (CD8+/CD4+FOXP3+). None of the changes observed were detected in the intra-epithelial site in any arm (NACT or NACT-bevacizumab). No differences were found in myeloid lineage (macrophage-like). The percentage of Treg populations and effector/regulatory cell ratio in the stroma were the only two variables significantly associated with progression-free survival (PFS). Conclusions: The addition of bevacizumab to NACT did not have an impact on PFS in the GEICO 1205 study. However, at the cellular level, changes in CD4+, CD8+ lymphocyte populations, and CD8+/CD4+FOXP3 ratio have been detected only at the stromal site. On the basis of our results, we hypothesize about the existence of mechanisms of resistance that could prevent the trafficking of T-effector cells into the epithelial component of the tumor as a potential explanation for the lack of efficacy of ICI in the first-line treatment of advanced epithelial ovarian cancer. See related commentary by Soberanis Pina and Oza, p. 12.
Fuente: Clinical Cancer Research, 2024, 30(1), 176-186
Editorial: American Association for Cancer Research
Año de publicación: 2024
Nº de páginas: 11
Tipo de publicación: Artículo de Revista
DOI: 10.1158/1078-0432.CCR-23-0771
ISSN: 1078-0432,1557-3265
Url de la publicación: https://doi.org/10.1158/1078-0432.CCR-23-0771
Leer publicación
TAVIRA, BEATRIZ
ISCAR, TERESA
MANSO, LUIS
SANTABALLA, ANA
GIL-MARTÍN, MARTA
GARCÍA GARCÍA, YOLANDA
ROMEO, MARGARITA
IGLESIDAS, MARÍA
ANA DE JUAN FERRE
BARRETINA-GINESTA, MARÍA PILAR
MANZANO, ARANZAZU
GABA, LYDIA
RUBIO, MARÍA JESÚS
ANDREA, CARLOS E. DE
GONZÁLEZ-MARTÍN, ANTONIO
Volver